糖酸酶是帕金森病驱动的神经元代谢缺陷的中心杆点
Alexandros C Kokotos1,2, Aldana M Antoniazzi2,3, Santiago R Unda2,3
1Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065.
bioRxiv : the preprint server for biology
|October 24, 2023
概括
糖酸酶1 (PGK1) 是神经终端ATP生产中的一个关键酶. 增强PGK1活动通过保护多巴胺神经元和逆转突触缺陷,显示出对帕金森病的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 代谢途径 代谢途径
背景情况:
- 帕金森病 (PD) 与潜在的治疗位,如糖酸酶1 (PGK1) 有关.
- PGK1是糖解中的最初的ATP生成酶.
- 以前的研究表明,PGK1活性增强剂可能会降低PD风险.
研究的目的:
- 研究PGK1在神经末端ATP产生中的作用及其与PD的相关性.
- 确定PGK1作为突触能量代谢中的速度限制酶.
- 为了探索PGK1对PD的治疗潜力.
主要方法:
- 进行了低代谢突触缺陷的抑制器屏幕.
- 评估了PGK1在神经末端ATP生产中的作用,在体外和体内.
- 在PD模型中检查了PGK1,PARK7 (DJ-1) 和PARK20 (Synaptojanin-1) 之间的相互作用.
主要成果:
- 鉴定出PGK1是神经末端ATP生产中的速度限制酶.
- 增加PGK1表达保护中脑多巴胺神经元免受氧多巴胺诱导的功能障碍.
- 在PGK1活性中发生的轻微变化在体外显著改善了突触功能.
- PGK1由PARK7 (DJ-1) 进行交叉调节,其活性可以逆转PARK20驱动的突触缺陷.
结论:
- 神经终端生物能量缺陷可能会导致PD易感性.
- PGK1是轴突糖解中的关键限制酶.
- 准PGK1为PD的治疗干预提供了一种机制方法.
更多相关视频
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
15.1K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.6K
相关概念视频
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Other Glycolytic Pathways
17
The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
17
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
